Cited by 49

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP

Rebeck, G.William, Moir, Robert D., Mui, Stina, Strickland, Dudley K., Tanzi, Rudolph E., Hyman, Bradley T.·2001·Molecular Brain Research

Abstract

In order to identify cell surface proteins that interact with the amyloid precursor protein (APP), we biotinylated H4 human neuroglioma cells in culture with a water soluble biotinylating agent, immunoprecipitated APP with an antibody specific to the intracellular domain, and probed the precipitated proteins with anti-biotin. In human neuroglioma cells overexpressing APP751, we found a high molecular weight protein that immunoprecipitated with APP. This band was identified as the low density lipoprotein receptor-related protein (LRP) by three criteria: first, the band immunolabeled with anti-LRP antibodies; second, the band bound the LRP receptor associated protein, RAP; and third, this band was present in LRP-expressing fibroblasts, but not LRP-deficient fibroblasts. In complementary experiments, we found that APP co-precipitated with LRP, with a preference for an isoform of APP containing the Kunitz protease inhibitor domain. Interaction of APP and LRP on the surface of living cells was demonstrated by crosslinking APP and LRP with the water-soluble cross-linking agent BS(3). APP and LRP were shown by confocal microscopy to colocalize in perinuclear structures, but to primarily remain separate in vesicles and on the cell surface. We propose that full-length APP can transiently interact with the receptor LRP on the cell surface, affecting the processing and intracellular transport of APP.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0169-328x(01)00006-7

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Blacker, 1998, Alpha-2 macroglobulin is genetically associated with Alzheimer disease, Nat. Genet., 19, 357, 10.1038/1243 · DOI · Paper page
  2. Borg, 1996, The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein, Mol. Cell. Biol., 16, 6229, 10.1128/MCB.16.11.6229 · DOI · Paper page
  3. Do, 1996, The alternatively spliced Kunitz protease inhibitor domain alters amyloid β protein precursor processing and amyloid β protein production in cultured cells, J. Biol. Chem., 271, 30929, 10.1074/jbc.271.48.30929 · DOI
  4. Guenette, 1996, Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein, Proc. Natl. Acad. Sci. USA, 93, 10832, 10.1073/pnas.93.20.10832 · DOI
  5. Haass, 1992, Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments, Nature, 357, 500, 10.1038/357500a0 · DOI
  6. Hollenbach, 1998, Confirmation of an association between a polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene and Alzheimer’s disease, Neurology, 50, 1905, 10.1212/WNL.50.6.1905 · DOI
  7. Hyman, 1992, Kunitz protease inhibitor containing amyloid precursor protein immunoreactivity in Alzheimer’s disease: a quantitative study, J. Neuropathol. Exp. Neurol., 51, 76, 10.1097/00005072-199201000-00009 · DOI
  8. Kang, 1997, Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer’s disease, Neurology, 49, 56, 10.1212/WNL.49.1.56 · DOI · Paper page
  9. Knauer, 1996, Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP), Brain Res., 740, 6, 10.1016/S0006-8993(96)00711-1 · DOI
  10. Koo, 1994, Evidence that production and release of amyloid β-protein involves the endocytic pathway, J. Biol. Chem., 269, 17386, 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
  11. Koo, 1996, Trafficking of cell surface amyloid β-protein precursor. 1. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody, J. Cell Sci., 109, 991, 10.1242/jcs.109.5.991 · DOI
  12. Kounnas, 1992, The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, α2-macroglobulin receptor and glucoprotein 330, J. Biol. Chem., 267, 21162, 10.1016/S0021-9258(19)36811-5 · DOI · Paper page
  13. Kounnas, 1995, LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation, Cell, 82, 331, 10.1016/0092-8674(95)90320-8 · DOI · Paper page
  14. Kounnas, 1992, The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A, J. Biol. Chem., 267, 12420, 10.1016/S0021-9258(18)42291-0 · DOI
  15. LaDu, 1995, Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid, J. Biol. Chem., 270, 9039, 10.1074/jbc.270.16.9039 · DOI · Paper page
  16. Lalazar, 1988, Site-specific mutagenesis of human apolipoprotein E: receptor binding activity of variants with single amino acid substitutions, J. Biol. Chem., 263, 3542, 10.1016/S0021-9258(18)68957-4 · DOI · Paper page
  17. Liao, 1998, Genetic association of an alpha-2 macroglobulin (Val 1000 Ile) polymorphism and Alzheimer’s disease, Hum. Mol. Genet., 7, 1953, 10.1093/hmg/7.12.1953 · DOI
  18. Moir, 1998, Relative increase in Alzheimer’s disease of soluble forms of cerebral Aβ amyloid protein precursor containing the Kunitz protease inhibitory domain, J. Biol. Chem., 273, 5013, 10.1074/jbc.273.9.5013 · DOI
  19. Narita, 1997, a2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein, J. Neurochem., 69, 1904, 10.1046/j.1471-4159.1997.69051904.x · DOI · Paper page
  20. Peraus, 1997, Late compartments of amyloid precursor protein transport in SY5Y cells are involved in β-amyloid secretion, J. Neurosci., 17, 7714, 10.1523/JNEUROSCI.17-20-07714.1997 · DOI
  21. Qiu, 1999, a2-macroglobulin enhances the clearance of endogenous soluble β-amyloid peptide via low density lipoprotein receptor-related protein in cortical neurons, J. Neurochem., 73, 1393, 10.1046/j.1471-4159.1999.0731393.x · DOI · Paper page
  22. Rebeck, 1995, Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low-density-lipoprotein receptor-related protein, Ann. Neurol., 37, 211, 10.1002/ana.410370212 · DOI · Paper page
  23. Selkoe, 1994, Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer’s disease, Annu. Rev. Cell Biol., 10, 373, 10.1146/annurev.cb.10.110194.002105 · DOI
  24. Simons, 1998, Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons, Proc. Natl. Acad. Sci. USA, 95, 6460, 10.1073/pnas.95.11.6460 · DOI
  25. Sisodia, 1993, Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system, J. Neurosci., 13, 3136, 10.1523/JNEUROSCI.13-07-03136.1993 · DOI
  26. Smith, 1990, Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein, Science, 248, 1126, 10.1126/science.2111585 · DOI
  27. Strickland, 1990, Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor, J. Biol. Chem., 265, 17401, 10.1016/S0021-9258(18)38172-9 · DOI · Paper page
  28. Strickland, 1995, LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism, FASEB J., 9, 890, 10.1096/fasebj.9.10.7615159 · DOI
  29. Strittmatter, 1996, Apolipoprotein E and Alzheimer’s disease, Annu. Rev. Neurosci., 19, 53, 10.1146/annurev.ne.19.030196.000413 · DOI · Paper page
  30. Tanzi, 1992, Assessment of amyloid β protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases, Am. J. Hum. Genet., 51, 273
  31. Trommsdorff, 1998, Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein, J. Biol. Chem., 273, 33556, 10.1074/jbc.273.50.33556 · DOI · Paper page
  32. Ulery, 2000, Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP), J. Biol. Chem., 275, 7410, 10.1074/jbc.275.10.7410 · DOI · Paper page
  33. Van Nostrand, 1990, Protease nexin-II (amyloid β protein precursor): a platelet a-granule protein, Science, 248, 745, 10.1126/science.2110384 · DOI
  34. Warshawsky, 1994, The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor, Proc. Natl. Acad. Sci. USA, 91, 6664, 10.1073/pnas.91.14.6664 · DOI
  35. Williams, 1992, A novel mechanism for controlling the activity of α2-macroglobulin receptor/low density lipoprotein receptor-related protein, J. Biol. Chem., 267, 9035, 10.1016/S0021-9258(19)50384-2 · DOI · Paper page
  36. Willnow, 1994, Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A, J. Cell Sci., 107, 719, 10.1242/jcs.107.3.719 · DOI

Cited by

Sorted by citations

Metadata

Authors
Rebeck, G. W., Moir, R. D., Mui, S., Strickland, D. K., Tanzi, R. E., & Hyman, B. T.
Venue
Molecular Brain Research
Publisher
Elsevier BV
Published
2001-03
Volume
87
Issue
2
Pages
238-245
ISSN
0169-328X
Cited by
49
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review